$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

$kavl Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000173112224000480 Filed on March 25, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$3.212M	$2.526M
YoY Change	27.14%	-11.12%
Cost Of Revenue	$2.013M	$1.986M
YoY Change	1.39%	-43.79%
Gross Profit	$1.198M	$540.1K
YoY Change	121.83%	-178.17%
Gross Profit Margin	37.31%	21.38%
Selling, General & Admin	$2.716M	$3.547M
YoY Change	-23.42%	69.63%
% of Gross Profit	226.7%	656.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$196.8K	$116.00
YoY Change	169529.31%
% of Gross Profit	16.42%	0.02%
Operating Expenses	$2.913M	$3.547M
YoY Change	-17.88%	69.63%
Operating Profit	-$1.715M	-$3.007M
YoY Change	-42.98%	8.08%
Interest Expense	-$299.9K	$11.95K
YoY Change	-2609.79%
% of Operating Profit
Other Income/Expense, Net	-$398.3K	$11.95K
YoY Change	-3432.91%
Pretax Income	-$2.113M	-$2.995M
YoY Change	-29.45%	7.65%
Income Tax	$720.00
% Of Pretax Income
Net Earnings	-$2.181M	-$2.995M
YoY Change	-27.17%	7.65%
Net Earnings / Revenue	-67.92%	-118.57%
Basic Earnings Per Share	-$0.76	-$1.12
Diluted Earnings Per Share	-$0.76	-$0.05
COMMON SHARES
Basic Shares Outstanding	2.846M shares	56.17M shares
Diluted Shares Outstanding	2.855M shares	2.675M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$591.3K	$3.774M
YoY Change	-84.33%	-32.5%
Cash & Equivalents	$0.00	$3.774M
Short-Term Investments
Other Short-Term Assets	$369.0K	$316.6K
YoY Change	16.55%	-10.94%
Inventory	$2.331M	$3.761M
Prepaid Expenses	$369.0K	$316.6K
Receivables	$744.0K	$518.3K
Other Receivables	$0.00	$2.026M
Total Short-Term Assets	$4.035M	$10.40M
YoY Change	-61.18%	-56.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$962.3K	$1.155M
YoY Change	-16.71%	2123.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.668K	$3.364K
YoY Change	-20.69%
Total Long-Term Assets	$12.23M	$2.639M
YoY Change	363.64%	4979.27%
TOTAL ASSETS
Total Short-Term Assets	$4.035M	$10.40M
Total Long-Term Assets	$12.23M	$2.639M
Total Assets	$16.27M	$13.03M
YoY Change	24.81%	-45.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.718M	$81.27K
YoY Change	2014.43%	-99.13%
Accrued Expenses	$884.8K	$675.5K
YoY Change	30.99%	74.19%
Deferred Revenue		$12.10K
YoY Change
Short-Term Debt	$821.9K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.704M	$3.787M
YoY Change	-2.18%	-61.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$817.1K	$1.006M
YoY Change	-18.81%	2257.55%
Total Long-Term Liabilities	$817.1K	$1.006M
YoY Change	-18.81%	2257.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.704M	$3.787M
Total Long-Term Liabilities	$817.1K	$1.006M
Total Liabilities	$4.522M	$4.793M
YoY Change	-5.67%	-51.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.88M	-$22.63M
YoY Change	45.31%
Common Stock	$2.863K	$56.17K
YoY Change	-94.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.75M	$8.242M
YoY Change
Total Liabilities & Shareholders Equity	$16.27M	$13.03M
YoY Change	24.81%	-45.26%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.181M	-$2.995M
YoY Change	-27.17%	7.65%
Depreciation, Depletion And Amortization	$196.8K	$116.00
YoY Change	169529.31%
Cash From Operating Activities	$244.9K	$91.22K
YoY Change	168.48%	-104.28%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$3.480K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$3.480K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-187.3K
YoY Change
NET CHANGE
Cash From Operating Activities	244.9K	$91.22K
Cash From Investing Activities	0.000	-$3.480K
Cash From Financing Activities	-187.3K
Net Change In Cash	57.64K	$87.74K
YoY Change	-34.3%	-104.04%
FREE CASH FLOW
Cash From Operating Activities	$244.9K	$91.22K
Capital Expenditures	$0.00	$3.480K
Free Cash Flow	$244.9K	$87.74K
YoY Change	179.12%	-104.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	kavl	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2024Q1	kavl	Inventory Deposit Related Party InventoryDepositRelatedParty	273060	usd
CY2023Q4	kavl	Inventory Deposit Related Party InventoryDepositRelatedParty	0	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	369027	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	430668	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	4035411	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6905427	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2668	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2842	usd
CY2024Q1	kavl	Intangible Assets Non Current IntangibleAssetsNonCurrent	11271710	usd
CY2023Q4	kavl	Intangible Assets Non Current IntangibleAssetsNonCurrent	11468309	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	959594	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1008428	usd
CY2024Q1	us-gaap	Assets Assets	16269383	usd
CY2023Q4	us-gaap	Assets Assets	19385006	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	304595	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	374332	usd
CY2024Q1	kavl	Due To Other Related Party Classified Current DueToOtherRelatedPartyClassifiedCurrent	1413691	usd
CY2023Q4	kavl	Due To Other Related Party Classified Current DueToOtherRelatedPartyClassifiedCurrent	2474817	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	821889	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	799471	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	695442	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736194	usd
CY2024Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	50000	usd
CY2023Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	0	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	229548	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	392406	usd
CY2024Q1	kavl	Long Term Debt And Capital Lease Obligation LongTermDebtAndCapitalLeaseObligation	189329	usd
CY2023Q4	kavl	Long Term Debt And Capital Lease Obligation LongTermDebtAndCapitalLeaseObligation	184568	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3704494	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4961788	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	817106	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	866207	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4521600	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5827995	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2793386	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2793386	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2863	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2793	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	44621654	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	44317266	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32877634	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30763948	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11747783	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13557011	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16269383	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19385006	usd
CY2024Q1	kavl	Royalty Revenue RoyaltyRevenue	240000	usd
CY2023Q1	kavl	Royalty Revenue RoyaltyRevenue	105572	usd
CY2024Q1	kavl	Excise Tax On Products ExciseTaxOnProducts	21607	usd
CY2023Q1	kavl	Excise Tax On Products ExciseTaxOnProducts	18574	usd
CY2024Q1	us-gaap	Revenues Revenues	3211573	usd
CY2023Q1	us-gaap	Revenues Revenues	2525918	usd
CY2024Q1	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	2013435	usd
CY2023Q1	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	1985800	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	2013435	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1985800	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1198138	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	540118	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	404892	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	588910	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2507868	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2958069	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	2912760	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3546979	usd
CY2024Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	98432	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	-0	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-299917	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11952	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-398349	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11952	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2112971	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2994909	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	715	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2113686	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2994909	usd
CY2024Q1	kavl	Preferred Stock Dividend PreferredStockDividend	67500	usd
CY2023Q1	kavl	Preferred Stock Dividend PreferredStockDividend	-0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2181186	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2994909	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.76
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2854850	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2854850	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2674719	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2674719	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13557011	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	62000	usd
CY2024Q1	kavl	Preferred Stock Dividends Income Statements Impact PreferredStockDividendsIncomeStatementsImpact	67500	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	309958	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2113686	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	11747783	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1435787	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2994909	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8241658	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2113686	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2994909	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	196773	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	116	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	111239	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2024Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	98432	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	0	usd
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	309958	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1435787	usd
CY2024Q1	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	48834	usd
CY2023Q1	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	46949	usd
CY2024Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	319	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1125315	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-56315	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-194590	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-61641	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-109786	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2013435	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2521766	usd
CY2024Q1	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty	-273060	usd
CY2023Q1	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty	0	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-0	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1607302	usd
CY2024Q1	kavl	Increase Decrease In Account Payable IncreaseDecreaseInAccountPayable	-69737	usd
CY2023Q1	kavl	Increase Decrease In Account Payable IncreaseDecreaseInAccountPayable	41242	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-1061126	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2350787	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-108252	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-423704	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-105572	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	50000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-32875	usd
CY2024Q1	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	162858	usd
CY2023Q1	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	-366956	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44340	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39789	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	244887	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91215	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3480	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3480	usd
CY2024Q1	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1106731	usd
CY2023Q1	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0	usd
CY2024Q1	kavl	Payments For Proceeds From Loans Payable PaymentsForProceedsFromLoansPayable	1293984	usd
CY2023Q1	kavl	Payments For Proceeds From Loans Payable PaymentsForProceedsFromLoansPayable	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-187253	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	57634	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	87735	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	533659	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3685893	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	591293	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3773628	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	111239	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	67500	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zoIuY6l279zj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_864_zvH353KYRFGe">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	191341	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	252586	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	113243	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zQaYBn02SI76" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt"><span><b><span id="xdx_86A_zwMmzr3MMD4d">Credit Risk</span> </b></span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span>Financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of purchases of inventories, accounts payable, accounts receivable, and revenue. The Company performs periodic credit evaluations of its customers and generally does not require collateral on trade receivables. Historically, the Company has not experienced significant credit losses. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p>
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	381512	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	381512	usd
CY2024Q1	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	50000	usd
CY2023Q4	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	0	usd
CY2024Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	229548	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	392406	usd
CY2024Q1	kavl	Royalty Rate Discription RoyaltyRateDiscription	The royalty paid by PMPSA to KBI will no longer be based on sales price of the Product being sold, but rather on the volume of liquid contained within Product being sold. The royalty will be on a sliding scale of between $0.08 to $0.16 per sale based on the volume of liquid contained in the Product, increasing to between $0.10 to $0.20 per sale upon meeting certain sales milestones.
CY2024Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	511192	usd
CY2024Q1	kavl	Revenue From Sale RevenueFromSale	474378	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	599201	usd
CY2023Q1	kavl	Revenue From Sale RevenueFromSale	432000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.7568	pure
CY2023Q4	kavl	Carrying Value Of Loan CarryingValueOfLoan	0	usd
CY2023Q4	kavl	Unamortized Debt Discount And Issuance Costs UnamortizedDebtDiscountAndIssuanceCosts	136705	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11795975	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	524265	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11795975	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	327666	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2024Q1	us-gaap	Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension	P14Y3M18D
CY2023	us-gaap	Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension	P14Y7M6D
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	196599	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	589799	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	786398	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	786398	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	786398	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	786398	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	7536319	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11271710	usd
CY2024Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1200000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1728000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	783889	usd
CY2024Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	51825	usd
CY2023Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	800000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1160000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	134176	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	8681	usd
CY2023	kavl	Commitment Fee Shares CommitmentFeeShares	19048	shares
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	38273	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	122273	usd
CY2024Q1	kavl	Carrying Value Of Loan CarryingValueOfLoan	0	usd
CY2024Q1	kavl	Unamortized Debt Discount And Issuance Costs UnamortizedDebtDiscountAndIssuanceCosts	513295	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	98432	usd
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2024Q1	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-48340	usd
CY2023Q1	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-46949	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	959594	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1008428	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	189329	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	184568	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	817106	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	866207	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1006435	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1050775	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	172137	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	238800	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	253614	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	274946	usd
CY2024Q1	kavl	Lessee Operating Lease Liability Payments Due After Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour	175989	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1115486	usd
CY2024Q1	kavl	Lessee Operatings Lease Liability Undiscounted Excess Amount LesseeOperatingsLeaseLiabilityUndiscountedExcessAmount	109051	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1006435	usd
CY2024Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-21 reverse stock split
CY2024Q1	kavl	Rounding From Reverse Split Shares RoundingFromReverseSplitShares	52949	shares
CY2024Q1	kavl	Common Stock Share Issued CommonStockShareIssued	16667	shares
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	62000	usd
CY2024Q1	kavl	Unrecognized Expenses Related To Options UnrecognizedExpensesRelatedToOptions	3594567	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y9M3D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2024Q1	kavl	Inventory Quality Control Expenses InventoryQualityControlExpenses	273060	usd
CY2023Q1	kavl	Inventory Quality Control Expenses InventoryQualityControlExpenses	3697210	usd
CY2024Q1	kavl	Service Agreement Description ServiceAgreementDescription	(i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years.
CY2024Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	0	usd
CY2023Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	28318	usd

Files In Submission

Name	View Source	Status
0001731122-24-000480-index-headers.html	Edgar Link	pending
0001731122-24-000480-index.html	Edgar Link	pending
0001731122-24-000480.txt	Edgar Link	pending
0001731122-24-000480-xbrl.zip	Edgar Link	pending
e5504_10q.htm	Edgar Link	pending
e5504_ex31-1.htm	Edgar Link	pending
e5504_ex31-2.htm	Edgar Link	pending
e5504_ex32-1.htm	Edgar Link	pending
e5504_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kavl-20240131.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kavl-20240131_cal.xml	Edgar Link	unprocessable
kavl-20240131_def.xml	Edgar Link	unprocessable
kavl-20240131_lab.xml	Edgar Link	unprocessable
kavl-20240131_pre.xml	Edgar Link	unprocessable
e5504_10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

2024 Q1 Form 10-Q Financial Statement

#000173112224000480 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL Kaival Brands Innovations Group, Inc. Stock $kavl

2024 Q1 Form 10-Q Financial Statement

#000173112224000480 Filed on March 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl